chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient called on the phone and stated that he started to have blurred vision in one eye starting 2 weeks after his 1st covid shot.
reported itchiness around the site of injection and arm soreness that started about 24 hours after receiving the vaccine that lasted a duration of about 2 weeks. About a week after receiving the Moderna COVID-19 vaccine  also noticed a rash from the injection site down her arm that lasted about a week. denied taking anything for the itchiness/rash but did take an over the counter pain reliver for the soreness.  All symptoms resolved around the two week mark following her injection but  is still experiencing some soreness in the arm in which she received the vaccine.
Noticeable difficulty in urination.   While I was eventually able to, starting was very slow and flow was low.  My reaction is reminiscent of  what I experience after a dose of a cold symptoms treatment like NyQuil and say Afrin spray.
PT EXP PAIN AND STINGING AT SOI AFTER RECEIPT OF ENGERIX-B VACCINE.   TREATMENT:PT COUNSELING.  DOSE #2 15Jan90 PT EXP SAME SYMPTOMS.
No adverse effects were reported in the patient; a patient received a dose of ROTATEQ following a temperature excursion /Temperature; LOWEST Temperature BELOW 36°F/2°C (25F); This spontaneous report was received from a officer manager referring, to a patient of unknown age and gender. The patient concurrent conditions, pertinent medical history, concomitant medications, and previously drugs reactions or allergies were not provided.  On 16-AUG-2019, date the patient was vaccinated with a dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) as for prophylaxis. (strength, formulation, dose, dose number and route of administration were not reported; lot number was reported as R042223; expiration date: 24-MAY-2020 (invalid); following a temperature excursion. No adverse effects were reported in the patient.  The temperature of excursion was below of 36 degrees Fahrenheit/2 degrees Celsius  (25 degrees Fahrenheit), the time frame was reported as three hours (product storage error), without a previous temperature excursion. A digital data logger was used.
About 7-10 days after the shot, shestarted to feel joint pain, mostly on right hip/left hip, low back and it just got progressively worst and the pain spread to locations on the right shoulder and other parts of the body with prior surgery or medical interventions. The pain was so bad that she could not put on socks and shoes on the feet. There were pain on the left side as well. It was hard to her to sleep at times. Sometimes she had chills and low grade fever (99-100 F) from time to time. She had concern about the stiffness and the severe joint pain. The left leg end up being shorter than the right leg.  She had a rheumatologist, checked her joints for RA with blood works and X-ray. The tests were re-run again to be sure. Dr. had her checked for COVID-19 but it was negative. She will have the antibodies test done this week to be sure that it wasn't something else relating autoimmune disease. She also saw a chiropractor and the diagnosis was that her legs were different lengths and it was her body's natural response to compensate what was happening. Dr. is her acupuncturist, diagnosed her with "heat in her body". She put her on herbs to relieve the "heat".  Before it started, she was diagnosed with fibromyalgia. She was active and functional without medication with low grade pain throughout the day. Now it's severe and chronic. She was also diagnosed with mild arthritis and was getting cortisone injections in the past. However she was active had good quality of life before the shot.
Patient had no reaction. He was given his 4th dose and he is under 50 yo
25Apr2022 COVID-19 test: Positive; 25Apr2022 COVID-19 test: Positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4396534-00 (AbbVie).  A 21-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation; adalimumab (HUMIRA), (Batch/Lot number: unknown) at unk (citrate free), subcutaneous for psoriatic arthropathy, rheumatoid arthritis. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 25Apr2022, outcome "unknown", COVID-19 (medically significant) with onset 25Apr2022, outcome "recovering" and all described as "25Apr2022 COVID-19 test: Positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (25Apr2022) Positive. The action taken for adalimumab was unknown.  Clinical Course: Solicited report by a consumer of an adult female with events of non-serious COVID, hives at injection site and bump at injection site with Humira (Adalimumab). The patient was treated with Benadryl. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Daily Dose: 2) 1 in 1 once. Route of Admin: Intramuscular. Indications for Use: COVID19 Vaccination. On an unknown date patient experienced COVID, hives at injection site and bump at injection site Pfizer BioNTech COVID19 Vaccine (tozinameran) was also considered suspect. COVID-19 (COVID-19): Action(s) taken with drug: Unknown; Causality as per reporter (Drug/Vaccine): Probable; Dechallenge: N/A. The reporter's causality for the event(s) of COVID with Humira (Adalimumab) was a reasonable possibility. The reporter's causality for the event(s) of hives at injection site and bump at injection site was not provided.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
12-24 hours after vaccination,  I experienced moderate body aches, joint pain, headache, and fatigue. Recovered after 48 hours.  3 days after vaccination, I?m experiencing pain, redness, swelling, and itching just below the vaccination site on my left arm. Still experiencing these symptoms.
Severe muscle pains through out entire body starting 1 week after injection; daily headaches; extreme fatigue; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 31Jul2021 10:00 (Lot number: Fc3180) at the age of 50 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing); "Renal tubular acidosis" (unspecified if ongoing); "known allergies: Sulfa" (unspecified if ongoing); "covid prior vaccination: Yes" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; LINZESS. Past drug history included: Reglan, reaction(s): "known allergies: reglan". The following information was reported: MYALGIA (non-serious) with onset 07Aug2021, outcome "not recovered", described as "Severe muscle pains through out entire body starting 1 week after injection"; HEADACHE (non-serious) with onset 07Aug2021, outcome "not recovered", described as "daily headaches"; FATIGUE (non-serious) with onset 07Aug2021, outcome "not recovered", described as "extreme fatigue". The events "severe muscle pains through out entire body starting 1 week after injection", "daily headaches" and "extreme fatigue" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of myalgia, headache, fatigue.  Additional information: Facility type vaccine: Pharmacy or Drug Store. The patient did not test for COVID tested post vaccination. The patient did not receive other vaccine in four weeks.  Follow-up attempts are completed. No further information is expected.
The patient began to develop progressive weakness of both upper and lower extremities associated with shock like sensations in legs, approximately 1 week after receiving H1N1 vaccine patient has received 1 course 2gm/kg 1 IVIG.  Still being evaluated.  GBS mild.
Pt received 2nd dose pfizer covid-19 vaccine dose on 5/26/21. Per pt, he has body aches, blurry vision during movement, headache and feels on and off dizziness even when at rest.
Product temperature excursion issue; Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination. No Medical History information was reported.On 01-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided.For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.Concomitant medication details were not provided. Treatment details were not provided.There was an excursion from their freezer on 01-Oct-2021. They used the excursion tool but there is no option for the excursion they experienced. The tool only gives options for excursions above one hour and not less than, so she does not knowhow to do the analysis. She states that her team already knows the recommended temperatures and wants to know if the vials were still okay to be used because they were administered to 118 patients.
15-20 minutes after receiving FluMist, Varivax, and Tdap. Mother called clinic. Pt had on eye swollen and other eye starting to swell. Told to call 911 and take to ER.  MR received from PCP revealing a healthy 12 yr. old who received Varivax, Boostrix, and Flumist on 10/30/2006 and within 15-20 minutes developed swelling of the eyes.  He was taken to the ER where he was treated with Benadryl, and was doing well per MD report. Hospital MR received documenting visit for c/o itching, facial swelling, mouth swelling, and trouble breathing. PE: WNL with peri-orbital erythema. Patient had Benadryl and symptoms were resolving. DX: Allergic reaction.
This spontaneous report was received from a healthcare worker. The reporter informed that an unknown number of patients (no details provided) had been vaccinated with improperly stored RECOMBIVAX HB (lot number, dose, dose number and route not reported). The vaccines were exposed to 30 degrees Fahrenheit for 15 hours. No adverse effect reported. This case is linked to case reports 1210USA001182 and 1210USA010301 (same reporter; same medication error reported for other vaccines). Additional information has been requested.
1st dose 11 months ago; This case was reported by a consumer and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st part of Shingles vaccination 11 months ago).   On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 23-NOV-2022  Reporter's comment: The case was self reported by the patient. The patient asked should he/she bother taking the second dose.  Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingles vaccine, which led to incomplete course of vaccination.
Iz admin, both on R and L thigh 20 min after Iz's both legs redden and slightly swollen. Ice pack applied to areas.
sore right injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore right injection site arm) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Aug-2021, the patient experienced VACCINATION SITE PAIN (sore right injection site arm). At the time of the report, VACCINATION SITE PAIN (sore right injection site arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-327938 (Patient Link).
Developed shingles 2 1/2 weeks after first shot.  Had second shot on 3/19/2021.  Treated shingles with steroid cream, Valtrex, Gabapentin.  Still have more shingles at this date
Patient received first dose of vaccine on 4/18/2021, and second dose on 5/22/2021.  Now presents with pericarditis on 5/24/2021.  I know there has been some potential association of pericarditis with vaccination
Fever    Moderate amount of edema noted from under left axillary to the deltoid area (with two pools of edema). Injection site, raised and very red with purplish discoloration (not like a bruise). Shingles rash started < 48 hrs (under left breast  and down left ar    Narrative: Seen MD a couple of days after the injection (72 hours) after injection.
2 days post vaccine this patient developed a generalized rash over torso, preceded by body aches, headaches, and fatigue.
This case was reported by a physician via call center representative and described the occurrence of swelling in a 12-year-old male patient who received BEXSERO. In April 2016, the patient received BEXSERO .5 ml. In April 2016, less than a month after receiving BEXSERO, the patient experienced swelling, redness and pain. On an unknown date, the outcome of the swelling, redness and pain were recovered/resolved. It was unknown if the reporter considered the swelling, redness and pain to be related to BEXSERO. Additional details were provided as follows: The events lasted for 1 week.
Felt stoned; Headache; Chills; Fever; Nausea; This is a spontaneous report from a non-contactable consumer (patient). A 69-year-old, non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN6201 and expiry date not reported) via an unspecified route of administration, on 18Feb2021 14:00 (at the age of 69-year-old), as dose 1, single, for COVID-19 immunisation. Medical history included allergy to Barium. Concomitant medication included alprazolam (manufacturer unknown) for unspecified indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had felt stoned, experienced a bad headache for 3 days, felt chills, fever and nausea on 18Feb2021 at 14:15 which lasted one week. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of events felt stoned, headache, chills, fever, and nausea were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Appendicitis. Appeared on Saturday 7.17 after 1st dose was administered on 7.14. surgery to remove appendix on 7.18.21.
This is a spontaneous report from a contactable pharmacy technician and a contactable pharmacist via a Pfizer representative. This physician reported similar events for 3 patients, this is the second of three reports. A female patient over 65 years old of unknown ethnicity received PREVNAR 13 for Protection against pneumococcal pneumonia via an unspecified route at single dose on unknown date. Relevant medical history and concomitant medication were unknown. On unknown date the patient experienced swelling of injection site. The outcome of the event was unknown. Sender's Comments: Linked Report(s): US-PFIZER INC-2017231461 Same reporter/ product, similar events, different patients; US-PFIZER INC-2017231548 Same reporter/ product, similar events, different patients.
Left thigh was red, warm to the touch, and swollen from upper thigh to knee.  The child would not bend his knee no fever. Mom iced the leg and gave Motrin.
Pt received flu vaccine at 0950 on 12/09/03 and was discharged from clinic. Prior to vaccine, mom stated that pt had no allergies. Pt returned to clinic at 1015 stating that he felt funny and was having trouble breathing. Pt brought to room. BP and pulse Ox monitored. IV fluids given. Pt discharged at 1200.
PT RECIEVED THE VARICELLA VACCINE 09/20/2004 & WAS DIAGNOSED WITH CHICKEN POX ON 08/01/2007.
Information has been received from Sanofi Pasteur MSD (SPM) (MFR# 2015453388) on 29-DEC-2015. This spontaneous report as received from a Nurse Practitioner via Pfizer (MFR# 2015427765) refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (route, lot# and dose were unknown). On an unknown date the patient experienced allergy reaction. The outcome of the event was unknown. The causality was not reported. Additional information has been requested.
Dizziness, sweating, hot flashes, vomiting, paleness.  fever developed 1/17/06.  Several hours later (8-9hrs) 101 degree.
Severe puffiness of eyes.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number E69263), via an unspecified route of administration in the right arm on 25Jan2021 at 09:15 (at the age of 37-years) as a single dose for Covid-19 immunization. Historical vaccine included the first dose of BNT162B2 (Lot Number E61284) on 04Jan2021 at 09:00 (at the age of 37-years) in the right arm for Covid-19 immunization. The patient's medical history and concomitant medications was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 26Jan2021 11:45, the patient experienced severe puffiness of eyes. The patient was seen in emergency department or urgent care. The patient was treated for the severe puffiness of eyes with diphenhydramine hydrochloride (BENADRYL). The clinical outcome of the event severe puffiness of eyes was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
feels like she might be back in bed again today; whole body aches/whole body was hurting like someone beat her up/hurting all over; had a bad case of the flu.; Her head felt like "migraine  headache/headache from hell; vomiting last night; felt weird; arm is sore; This is a spontaneous report from a contactable consumer or other non hcp(patient). A 66-years-old female patient received BNT162B2 (Pfizer covid 19 vaccine, formulation: solution for injection, Batch/Lot Number: FC3180), via an unspecified route of administration, administered in Arm Left on 28Aug2021 (at the age of 66-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included myocardial infarction from an unknown date and unknown if ongoing Verbatim: massive heart attack, hypertension from an unknown date and unknown if ongoing Verbatim: Hypertension. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included verapamil (VERAPAMIL) taken for an unspecified indication, start and stop date were not reported. On 29Aug2021, the patient experienced whole body aches/whole body was hurting like someone beat her up/hurting all over, had a bad case of the flu, her head felt like "migraine headache/headache from hell, vomiting last night, felt weird, arm is sore, feels like she might be back in bed again today. The outcome of the events was unknown.  PSCC Communication: Report 1 of 2. Caller advised to follow up with PCP if she feels it is necessary.
anxiety attack; 2 mins after the shot left arm felt heavy and was hard to move, tingling/dead feeling; 2 mins after the shot left arm felt heavy and was hard to move, tingling/dead feeling; 2 mins after the shot left arm felt heavy and was hard to move, tingling/dead feeling; in the evening arm swelled/swelling went down to size of pin hole; there was a welt at the vaccination site / there was still a little knot on arm; fever; night sweats; body rash/ rash beneath eyes; blister sores; swelling of eyes; arm was painful and is still; This is a spontaneous report from a contactable consumer. A 29-years-old female patient, a registered nurse, received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, Lot number BK9231, in Hospital, via an unspecified route of administration in left arm on 04Jan2021 at 14:00 at single dose for COVID-19 immunization. Medical history was none. The patient was not pregnant at the time of the vaccination. Concomitant medications included ibuprofen and cetirizine hydrochloride (ZYRTEC). The patient reported that 2 mins after the shot, her left arm felt heavy and was hard to move and, on 04Jan2021 at 14:15 she had tingling/dead feeling; in the evening arm swelled and there was a welt at the vaccination site. On an unknown date in Jan2021 she had fever at 102 °F for 48 hours and swelling went down to size of pin hole; her arm was painful and was still sore, there was still a little knot on arm. On 07Jan2021 she experienced an anxiety attack; 20 days after, in Jan2021 the patient experienced night sweats. She also experienced body rash and little blister sores on her body and both arms, swelling of eyes and rash beneath eyes. The events resulted in doctor or other healthcare professional office/clinic visit. No treatment was administered to the patients for the events. On 25Jan2021 the patient underwent COVID-19 test via Nasal Swab which showed negative results. The event "Fever" resolved after 48 hours, whereas the outcome of all the reported events was unknown at time of the report.
The afternoon and evening on the day I got my Bivalent COVID-19 vaccine I noticed that I started getting hives. They then kept showing up and were all over the only places I did not get them was my stomach, my back, the palms of hands, and the bottoms of my feet. I was asked by my doctor when I saw him on that following Monday about the inside of my mouth and I did not have them there. I have also had a cough that is a congestive cough since I had the shot, but it is also allergy season here, but this has come on at the same time as these hives. The hives were so itchy I could not sleep they are very red and very raised- they were hot to the touch and then they also had like a head on them. It seemed after a few days that it had like a head like a pimple and then they would open up and drain. They are now like scabbed over- it's like I had these blister pimples. They are still kind of showing up as well, but they are smaller and not in as large numbers. The doctor gave me an 8 day course of prednisone and also to take Zyrtec as well. I would not say I am recovered but is greatly improved.